MEDICATION MANAGEMEN T 203 G. The client seemed to minimize his/her noncompliance with prescribed medications and was confronted about this. 3. Obtain Blood Levels (3) A. A blood draw was conducted, and the client's blood levels for specific medications have been assessed. B. The analysis of the client's blood chemistry indicates substantial compliance with his/her medication regimen. C. An analysis of the client's blood chemistry indicates substantial noncompliance with his/her medication regimen. D. The client' s suspected pattern of medication use (based on blood chemistry studies) was reflected to him/her. 4. Conduct Motivational Interviewing (4) A. Motivational interviewing techniques were used to help assess the client's preparation for change. B. The clie nt was assisted in identifying his/her stage of change regarding his/her substance abuse concerns. C. It was reflected to the client that he/she is currently building motivation for change. D. The client was assisted in strengthening his/her commitment t o change. E. The client was noted to be participating actively in treatment. 5. Review and Supplement Medication Knowledge (5) A. The client was requested to identify the reason for each of his/her medications. B. The client was provided with positive feedback as he/she displayed a clear understanding of the reasons for each of his/her medications. C. The client was provided with written information about his/her medications, the acceptable dosage levels, and the side effects. D. The client reported t hat he/she has read the written information provided to him/her and has gained a better understanding of his/her medications. E. The client has not read the written information provided to him/her and was redirected to do so. 6. Process Fears Regarding Medication ( 6) A. The client was requested to describe the fears that he/she may experience regarding the use of his/her medications. B. Myths and misinformation regarding the client's understanding and fears of his/her medications were corrected. C. The client's fears were reviewed, discussed, and processed to conclusion. D. The client was provided with positive feedback regarding his/her increased comfort with his/her use of medications. E. The client tended to minimize or deny his/her fears regardin g his/her medications, and he/she was encouraged to be more open about these concerns. 